Among these CHROMR-associated miRNAs, circulating miR-27b was found to be downregulated in smokers predisposed to PAD [135], while circulating miR-33a was found to be elevated in T2D patient serum [136], and inhibition of miR-33a/b reduced atherosclerosis [137]. This evidence concerns the gene CHROMR and peripheral arterial disease.